Alzheimer’s disease: newer modalities in treatment
No Thumbnail Available
Date
2024-12
Journal Title
Journal ISSN
Volume Title
Publisher
Medip Academy
Abstract
Alzheimer’s disease (AD) remains insurmountable despite a long history of research and clinical development. It is projected to rise in the coming decades of public health due to the aging population worldwide. Understanding the basic tenets of the disease and targeting key steps remains a time-tested approach even for AD. Apart from the currently available treatment options namely NMDA blockers, and acetylcholinesterase inhibitors, recently monoclonal antibodies that target A? amyloid protein are approved. This review highlights the key features of currently approved drugs along with promising drugs in clinical development.
Description
Keywords
AD, Monoclonal antibody, Degenerative brain disease, Clinical development for AD
Citation
Syed AR, Agha AAA, Mohamed IMS, Srinivasamurthy SK.. Alzheimer’s disease: newer modalities in treatment . International Journal of Basic & Clinical Pharmacology. 2024 Dec; 13(6): 915-921